Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12412500rdf:typepubmed:Citationlld:pubmed
pubmed-article:12412500lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12412500lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:12412500lifeskim:mentionsumls-concept:C0002198lld:lifeskim
pubmed-article:12412500lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12412500lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:12412500lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:12412500lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:12412500lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:12412500pubmed:issue4lld:pubmed
pubmed-article:12412500pubmed:dateCreated2002-11-4lld:pubmed
pubmed-article:12412500pubmed:abstractTextA multi-step purification procedure has been used for isolation of alpha 2M/LRP receptor from human placenta. Enzymatic properties of complexes of purified alpha 2M trypsin with alpha 2M/LRP receptor were studied. This complex is characterized by enzymatic activity measured by a kinetic procedure based on the trypsin reaction with synthetic substrate alpha 2N-benzoyl-D,L-arginine nitroparaanilide. Purified triple complexes of alpha 2M trypsin with alpha 2M/LRP had 22-28% residual trypsin activity, while that of trypsin complex with alpha 2-macroglobulin was 52-53%. Patients' blood samples were characterized by a high level of residual activity of the studied double and triple complexes only initially. A decrease in the activities of these complexes was observed in patients with high levels of malonic dialdehyde (by TBA-reactive products) combined with decreased level of superoxidedismutase-like activity.lld:pubmed
pubmed-article:12412500pubmed:languageruslld:pubmed
pubmed-article:12412500pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12412500pubmed:citationSubsetIMlld:pubmed
pubmed-article:12412500pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12412500pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12412500pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12412500pubmed:statusMEDLINElld:pubmed
pubmed-article:12412500pubmed:monthAprlld:pubmed
pubmed-article:12412500pubmed:issn0869-2084lld:pubmed
pubmed-article:12412500pubmed:authorpubmed-author:ZhlobaA AAAlld:pubmed
pubmed-article:12412500pubmed:authorpubmed-author:IvanovaS...lld:pubmed
pubmed-article:12412500pubmed:issnTypePrintlld:pubmed
pubmed-article:12412500pubmed:ownerNLMlld:pubmed
pubmed-article:12412500pubmed:authorsCompleteYlld:pubmed
pubmed-article:12412500pubmed:pagination7-11lld:pubmed
pubmed-article:12412500pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:12412500pubmed:meshHeadingpubmed-meshheading:12412500...lld:pubmed
pubmed-article:12412500pubmed:meshHeadingpubmed-meshheading:12412500...lld:pubmed
pubmed-article:12412500pubmed:meshHeadingpubmed-meshheading:12412500...lld:pubmed
pubmed-article:12412500pubmed:meshHeadingpubmed-meshheading:12412500...lld:pubmed
pubmed-article:12412500pubmed:meshHeadingpubmed-meshheading:12412500...lld:pubmed
pubmed-article:12412500pubmed:meshHeadingpubmed-meshheading:12412500...lld:pubmed
pubmed-article:12412500pubmed:meshHeadingpubmed-meshheading:12412500...lld:pubmed
pubmed-article:12412500pubmed:meshHeadingpubmed-meshheading:12412500...lld:pubmed
pubmed-article:12412500pubmed:meshHeadingpubmed-meshheading:12412500...lld:pubmed
pubmed-article:12412500pubmed:year2002lld:pubmed
pubmed-article:12412500pubmed:articleTitle[Properties and expression of the human activated alpha2-macroglobulin receptor].lld:pubmed
pubmed-article:12412500pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12412500pubmed:publicationTypeEnglish Abstractlld:pubmed
entrez-gene:4035entrezgene:pubmedpubmed-article:12412500lld:entrezgene